U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07532239) titled 'Survey of Knowledge, Practice, and Recommendation Behaviors Regarding Healthy Lifestyles A... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07530848) titled 'Perioperative Pharmacokinetics of Anesthetic Drugs and Complications in Overweight and Obe... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07530666) titled 'Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia' on April 01. ... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07531264) titled 'EMG-guided Neuro-Intermuscular Coordination Enhancement (NICE) Rehabilitation Through Huma... Read More
India, April 16 -- The New Moon in Aries on April 17, 2026, arrives with energy, urgency, and a nudge to finally go after what you have been thinking about for a while. If you have been waiting for a ... Read More
Goa, April 16 -- The Enforcement Directorate on Wednesday carried out early morning searches at business establishments linked to AAP Rajya Sabha MP Ashok Mittal and his son in Punjab, officials confi... Read More
New Delhi, April 16 -- The Central Bureau of Investigation (CBI) on Thursday filed its response in the Delhi High Court to the fresh affidavit submitted by AAP national convenor Arvind Kejriwal under ... Read More
Singapore, April 16 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 16 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 16 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More